| Net Cash Provided by (Used in) Operating Activities |
$584,000 |
USD |
41% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$154,000 |
USD |
-76% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,514,029 |
shares |
-86% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$430,000 |
USD |
-28% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$188,000 |
USD |
-6.9% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$8,250,000 |
USD |
22% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$8,759,000 |
USD |
23% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$840,000 |
USD |
-61% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$69,000 |
USD |
-65% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$871,000 |
USD |
-62% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$4,512,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$840,000 |
USD |
-36% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$496,000 |
USD |
-66% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$496,000 |
USD |
-66% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$31,000 |
USD |
-72% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,233,000 |
USD |
23% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$38,896,000 |
USD |
0.03% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$72,000 |
USD |
-68% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$509,000 |
USD |
29% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$2,145,000 |
USD |
-7.7% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$644,000 |
USD |
424% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |